ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,774, issued on July 21, was assigned to Innovative Cellular Therapeutics Holdings Ltd. (George Town, Cayman Islands) and Innovative Cellular Therapeutics Inc. (Rockville, Md.).
"Cell/gene therapies targeting MAGE-A4 peptide" was invented by Lei Xiao (Rockville, Md.), Chengfei Pu (Shanghai), Zhiyuan Cao (Shanghai), Xiaogang Shen (Shanghai), Dongqi Chen (Shanghai), Beibei Jia (Shanghai) and Le Tian (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compositions and methods for treating a subject having cancer associated with melanoma-associated antigen 4 (MAGE-A4) peptide. The disclosure includes the embod...